Company
Provides clinical-grade gut microbiome testing and has a therapeutics pipeline
Every investor coverage indicates participated in a round Microba Life Sciences raised.
Companies Microba Life Sciences acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Microba Life Sciences. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Street Talk reports BCAL Diagnostics' takeover plan for Genetic Signatures collapsed once the target's talks with Sonic-backed Microba surfaced, with a three-company combination now under discussion.
The two diagnostics companies have entered early-stage merger talks aiming to combine rapid pathogen testing with gut microbiome analysis, though both stress the discussions are preliminary with no terms agreed.
FaBA introduces its newly appointed commercialisation director, who discusses his microbiome industry background and the accelerator's co-funded research projects for industry partners.
Roundup of Australian manufacturing news: Matrak closes a Series A, Queensland Pacific Metals receives an R&D tax refund, ARENA funds a household energy trial, Ampcontrol appoints a transformation chief, plus policy and launch briefs.
Also @AuManufacturing
Techboard's monthly roundup cataloguing April 2022 Australian startup funding: megadeals, seed rounds, grants and crowdfunding, nine acquisitions, several ASX listings, and venture firms' fund news.
Techboard's March 2022 roundup of Australian funding: megadeals by Immutable, Saluda Medical, Linktree and Zeller, many smaller raises, acquisitions, an IPO, several fund closes, and companies still seeking capital.
Also Australian FinTech